(Q44014376)

28 November 2017

N-acetylcysteine for major depressive episodes in bipolar disorder (English)

1 reference

28 November 2017

1 reference

1 reference

10

1 reference

28 November 2017

Ashley I Bush

3

0 references

Gin Malhi

series ordinal

5

object named as

Gin S Malhi

1 reference

28 November 2017

6

Kristy Kohlmann

1 reference

28 November 2017

8

Ian Schapkaitz

1 reference

28 November 2017

9

Murray Anderson-Hunt

1 reference

28 November 2017

4

David L Copolov

1 reference

28 November 2017

7

Susan Jeavons

1 reference

28 November 2017

Pedro V Magalhães

1

1 reference

PubMed ID

22189927

28 November 2017

Olívia M Dean

series ordinal

2

1 reference

28 November 2017

1 December 2011

1 reference

Brazilian Journal of Psychiatry

28 November 2017

1 reference

28 November 2017

33

1 reference

28 November 2017

4

1 reference

28 November 2017

374-378

1 reference

Nosology, diagnostic challenges, and unmet needs in managing bipolar disorder

28 November 2017

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

Bipolar depression: overview and commentary

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

Psychosocial Disability in the Course of Bipolar I and II Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

Functioning and disability in bipolar disorder: an extensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

Bipolar Disorder: An Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

Serological observations in patients suffering from acute manic episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

Peripheral biomarkers and illness activity in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

Allostatic load in bipolar disorder: implications for pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

Glutathione: a novel treatment target in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

Effects of N-acetyl-cysteine treatment on glutathione depletion and a short-term spatial memory deficit in 2-cyclohexene-1-one-treated rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

Interaction of glutathione depletion and psychotropic drug treatment in prepulse inhibition in rats and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

Assessing oxidative pathway genes as risk factors for bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

Prefrontal cortex glutathione S-transferase levels in patients with bipolar disorder, major depression and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

N-acetyl cysteine for depressive symptoms in bipolar disorder--a double-blind randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

The Bipolar Depression Rating Scale (BDRS): its development, validation and utility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

Scale matters: the need for a Bipolar Depression Rating Scale (BDRS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

A rating scale for mania: reliability, validity and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

The bootstrap: a technique for data-driven statistics. Using computer-intensive analyses to explore experimental data

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

Effect size, confidence interval and statistical significance: a practical guide for biologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

Pramipexole for bipolar II depression: a placebo-controlled proof of concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

Dimensions of improvement in a clinical trial of N-acetyl cysteine for bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS1516-44462011000400011

10.1590/S1516-44462011000400011

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference

PubMed ID

22189927